scispace - formally typeset
M

Maarten L. Simoons

Researcher at Erasmus University Rotterdam

Publications -  416
Citations -  56017

Maarten L. Simoons is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 90, co-authored 415 publications receiving 54201 citations. Previous affiliations of Maarten L. Simoons include University of Arizona & University of Massachusetts Medical School.

Papers
More filters
Journal ArticleDOI

Third universal definition of myocardial infarction

TL;DR: Information on MI rates can provide useful information regarding the burden of CAD within and across populations, especially if standardized data are collected in a manner that …
Journal ArticleDOI

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

TL;DR: In this paper, the authors defined the definition of MI and established the following criteria for acute, evolving or recent MI: 1) Typical rise and gradual fall (troponin) or more rapid rise and fall (CK-MB) of biochemical markers of myocardial necrosis with at least one of the following: a) ischemic symptoms; b) development of pathologic Qwaves on the ECG; c) ECG changes indicative of ischemia (ST segment elevation or depression); or d) coronary artery intervention (e.g., coronary ang
Journal ArticleDOI

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

TL;DR: The If Inhibitor Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Dysfunction is evaluated as well as patients with Diabetes mellitus for Optimal management of Multivessel disease.
Journal ArticleDOI

Universal definition of myocardial infarction.

TL;DR: Information on myocardial infarction attack rates can provide useful data regarding the burden of coronary artery disease within and across populations, especially if standardized data are collected in a manner that demonstrates the distinction between incident and recurrent events.
Journal ArticleDOI

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

TL;DR: It is of great importance that guidelines and recommendations are presented in formats that are easily interpreted, and their implementation programmes must also be well conducted.